🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in the EU / 2025-523778-17-00
Terminated Phase I

A study to compare how the body absorbs 4 different forms of norucholic acid medicine (tablets, granules, and capsules) when taken with or without food in healthy adults

2025-523778-17-00 · tracked via the Priya Life Science EU tracker
Sponsor
Dr. Falk Pharma GmbH
Sponsor type
Pharmaceutical company
Therapeutic area
Not possible to specify
Decision date
30/06/2026
Enrollment target
32
Sites
Germany

Condition studied

Not applicable, healthy volunteers

Eligibility

Age group
18-64 years
Sex
Female, Male
Official registry record

This page summarises publicly available CTIS data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View 2025-523778-17-00 on CTIS ↗ ← All trials in the EU